Sociedad Americana de Hirudoterapia

The stomatogastric nervous system of the medicinal leech: its anatomy, physiology and associated aminergic neurons

Neuroanatomy study published in Journal of Experimental Biology (2018)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Farmacología salivalMesce KA et al. · The Journal of experimental biology, 2018

Abstract

Blood feeding is an essential and signature activity of the medicinal leech species Hirudo verbana. Despite keen interest in understanding the neuronal substrates of this behavior, a major component of the nervous system associated with feeding has remained overlooked. In this study, for the first time, we report on the presence and characteristics of five stomatogastric ganglia (STGs) comprising the visceral stomatogastric nervous system (STN) of the leech. Although a brief report was published by Ruth Hanke in 1948 indicating that a ring of three ganglia (not five) was associated with the cephalic ganglia, this information was never integrated into subsequent neurobiological studies of feeding. Here, the anatomical features of the STGs are described, as are the morphological and electrophysiological characteristics of neurons originating in them. We also determined that two of the five STGs (STG-1 and STG-3) each contained two relatively large (ca. 40 µm diameter) serotonergic neurons. The STN was also enriched with dopaminergic and serotonergic arborizations; however, no intrinsic dopaminergic somata were observed. The trajectory of the serotonergic large lateral (LL) neuron, a command-like cell for feeding, was documented to project directly to the STN and not to the jaw and pharyngeal musculature as previously reported, thus reopening the important question of how the LL cell activates and coordinates biting activity with pharyngeal swallowing. Additional studies revealed that the LL cell is excited by blood serum applied to the lip and is strongly inhibited by dopamine. These findings provide a new foundation for understanding the regulation and modulation of neural networks involved in feeding.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
Indexed MeSH termsAnimalsGanglia, InvertebrateHirudo medicinalisNervous SystemNervous System Physiological PhenomenaNeurons

Resumen

Comprehensive anatomy and physiology of the medicinal leech stomatogastric nervous system, including aminergic neurons controlling feeding behavior.

Por qué esto importa para la hirudoterapia

This study reported for the first time the anatomy and neuron characteristics of five stomatogastric ganglia comprising the visceral stomatogastric nervous system (STN) of the medicinal leech, identifying serotonergic and dopaminergic elements, documenting the projection of the large lateral (LL) command-like feeding neuron to the STN, and showing the LL cell is excited by blood serum at the lip and inhibited by dopamine. For ASH's domain, this is relevant as fundamental neurobiology underlying the blood-feeding behavior of medicinal leeches. However, the study is basic neuroscience with no direct therapeutic, secretome, or clinical implications; its relevance to hirudotherapy practice is indirect and foundational rather than translational.

Citación

The stomatogastric nervous system of the medicinal leech: its anatomy, physiology and associated aminergic neurons.

Mesce KA et al. · The Journal of experimental biology, 2018

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.